BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 26963950)

  • 1. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
    Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
    Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AP2S1 and GNA11 mutations - not a common cause of familial hypocalciuric hypercalcemia.
    Hovden S; Rejnmark L; Ladefoged SA; Nissen PH
    Eur J Endocrinol; 2017 Feb; 176(2):177-185. PubMed ID: 27913609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.
    Hendy GN; Canaff L; Newfield RS; Tripto-Shkolnik L; Wong BY; Lee BS; Cole DE
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1311-5. PubMed ID: 24731014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
    Marx SJ
    J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcimimetic Use in Familial Hypocalciuric Hypercalcemia-A Perspective in Endocrinology.
    Marx SJ
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3933-3936. PubMed ID: 28945857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.
    Mayr B; Schnabel D; Dörr HG; Schöfl C
    Eur J Endocrinol; 2016 May; 174(5):R189-208. PubMed ID: 26646938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misleading localization by
    Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
    BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the spectrum of genetic variants in the calcium-sensing receptor (CASR) gene in hypercalcemic individuals.
    Nissen PH; Rejnmark L
    Clin Endocrinol (Oxf); 2019 Nov; 91(5):683-690. PubMed ID: 31433865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
    Isaksen T; Nielsen CS; Christensen SE; Nissen PH; Heickendorff L; Mosekilde L
    Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Hong Kong Chinese kindred with familial hypocalciuric hypercalcaemia caused by
    Wong FCK; Wong WS; Kwok JSS; Tsui TKC; Lau KP; Chan MHM; Yuen YP
    F1000Res; 2019; 8():1612. PubMed ID: 31723423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
    Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypocalciuric hypercalcemia and related disorders.
    Lee JY; Shoback DM
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):609-619. PubMed ID: 30449544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A series of clinical cases of familial hypocalciuric hypercalcemia syndrome].
    Krupinova JA; Almaskhanova AA; Eremkina AK; Bibik EE; Vasilyev EV; Mokrysheva NG
    Probl Endokrinol (Mosk); 2020 Oct; 66(5):61-69. PubMed ID: 33369373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
    Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
    BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):798-807. PubMed ID: 19250271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.